Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -24.00 (-1.91%)
Bid:
1,232.00
Ask:
1,242.00
Spread: 10.00 (0.812%)
Market Cap: £564.58m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

7 Nov 2016 07:00

RNS Number : 4324O
Cohort PLC
07 November 2016
 

Cohort plc

("Cohort")

 

Contract Win

 

SEA secures contracts to supply traffic enforcement systems to TfL

 

Cohort, the independent technology group, is pleased to announce that its subsidiary SEA has been awarded contracts by Transport for London (TfL) to further develop and provide ongoing support of its Digital Traffic Enforcement System (DTES) and to develop and support a Parking Enforcement Solution (PES) mobile application.

 

The combined orders are valued at approximately £7m and include 10 years' of support for both systems. SEA originally developed the DTES system on behalf of TfL. DTES entered into service in 2009 and SEA has provided support over the entire period.

 

Andy Thomis, Chief Executive of Cohort, said:

 

"I am delighted that SEA continues to be involved in this important TfL programme. The addition of the PES system to work with DTES is an exciting development.

 

"This adds further visibility to our order book, which underpins a significant proportion of revenues for Cohort's current financial year."

 

Ends

This announcement includes inside information.

 

For further information please contact:

 

 

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

 

 

Investec Bank Plc

020 7597 5970

Keith Anderson / Daniel Adams

 

 

 

MHP Communications Limited

020 3128 8100

Reg Hoare / Jamie Ricketts / Ollie Hoare

 

 

 

NOTES TO EDITORS

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through five market-facing subsidiary companies:

MASS - a specialist systems house with a focus on electronic warfare operational support, cyber defence and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in sourcing, design and integration of surveillance and other electronic systems, as well as field support and training for the UK MOD and other government agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, providing a range of services, including independent technical evaluation of military aircraft safety, and design and delivery of large and small scale military training exercises. Owned by Cohort since flotation in March 2006;

SEA - an advanced systems and software business operating in the defence (naval systems, simulation, training and technology research), transport and offshore energy market sectors. Acquired by Cohort in October 2007.

EID - a Portugal based supplier of advanced electronics, communications and command and control products and systems for the global defence market, in which Cohort acquired a majority stake in June 2016.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 800 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey, Scotland and Portugal.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTAKQDBOBDDQDK
Date   Source Headline
15th Feb 202310:30 amRNSDirector/PDMR Shareholding
1st Feb 20239:42 amRNSTotal Voting Rights
27th Jan 20233:30 pmRNSEBT Purchase of Shares
20th Jan 20237:00 amRNSInvestor Presentation
16th Jan 20237:00 amRNSInterim Report 2022
3rd Jan 20234:00 pmRNSEBT Purchase of Shares
3rd Jan 20233:30 pmRNSTotal Voting Rights
22nd Dec 20225:14 pmRNSEBT Purchase of Shares
14th Dec 20224:51 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSHalf Year Results
5th Dec 202211:30 amRNSNotice of Results
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:36 pmRNSPrice Monitoring Extension
30th Nov 20223:18 pmRNSTotal Voting Rights
24th Nov 20227:00 amRNSMASS awarded contract extension
31st Oct 20224:50 pmRNSTotal Voting Rights
21st Oct 20224:40 pmRNSDirector/PDMR Shareholding
21st Oct 20229:44 amRNSDirector/PDMR Shareholding
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
5th Oct 20224:46 pmRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 202211:04 amRNSTotal Voting Rights
29th Sep 20225:18 pmRNSDirector/PDMR Shareholding
28th Sep 20227:00 amRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement and First Quarter Update
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSSEA AWARDED UPGRADE CONTRACT WITH MOD
31st Aug 20222:15 pmRNSTotal Voting Rights
25th Aug 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
24th Aug 20229:30 amRNSBlock listing Interim Review
12th Aug 202210:04 amRNSDirector Share Awards and Shareholdings
11th Aug 202212:06 pmRNSTransfer of Shares
10th Aug 20222:59 pmRNSDirector/PDMR Shareholding
29th Jul 202212:40 pmRNSTotal Voting Rights
28th Jul 20227:00 amRNSDirectorate Change
28th Jul 20227:00 amRNSPreliminary Results
26th Jul 202210:35 amRNSNotice of Results
25th Jul 20221:17 pmRNSHolding(s) in Company
19th Jul 20224:10 pmRNSHolding(s) in Company
19th Jul 20227:00 amRNSCohort plc extends banking facility
30th Jun 20223:21 pmRNSTotal Voting Rights
31st May 20221:31 pmRNSTotal Voting Rights
26th May 20227:00 amRNSFull Year Trading Update
29th Apr 20224:15 pmRNSTotal Voting Rights
25th Apr 20227:00 amRNSHolding(s) in Company
22nd Apr 20223:35 pmRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSDirector/PDMR Shareholding
4th Apr 20223:00 pmRNSBlock listing Interim Review
1st Apr 20227:00 amRNSContract Win
31st Mar 20223:05 pmRNSTotal Voting Rights
23rd Mar 20227:00 amRNSELAC SONAR CONTRACT WIN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.